Clinical Trial Update: Bosutinib in Elderly Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for bosutinib in elderly patients with chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Bosutinib (bosutinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED